CVS Health Corp. (NYSE: CVS) Q3 2020 earnings call dated Nov. 06, 2020
Corporate Participants:
Valerie C Haertel — Senior Vice President, Investor Relations
Larry J. Merlo — President and Chief Executive Officer
Karen S. Lynch — Executive Vice President, CVS Health and President, Aetna
Eva C. Boratto — Executive Vice President and Chief Financial Officer
Alan M. Lotvin — Executive Vice President, CVS Health and President CVS Caremark
Jonathan C. Roberts — Executive Vice President and Chief Operating Officer
Analysts:
Lisa Gill — J.P. Morgan — Analyst
Eric Percher — Nephron Research LLC — Analyst
Ricky Goldwasser — Morgan Stanley — Analyst
A.J. Rice — Credit Suisse — Analyst
Charles Rhyee — Cowen and Company — Analyst
George Hill — Deutsche Bank — Analyst
Lance Wilkes — Sanford C. Bernstein — Analyst
Michael Cherny — Bank of America Merrill Lynch — Analyst
Ann Hynes — Mizuho Securities — Analyst
Steven Valiquette — Barclays — Analyst
Justin Lake — Wolfe Research — Analyst
_____
To read the full earnings call transcript, click here.
Most Popular
CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q2 2024 financial results
Colgate-Palmolive Company (NYSE: CL) reported its second quarter 2024 earnings results today. Net sales increased 4.9% year-over-year to $5 billion. Organic sales increased 9%. Net income attributable to Colgate-Palmolive Company was $731
Key takeaways from Visa’s Q3 2024 earnings report
Credit card behemoth Visa, Inc. (NYSE: V) this week reported mixed results for the June quarter, with earnings matching expectations and sales slightly missing the view. Both numbers grew in
Southwest Airlines (LUV): A look at the airline’s performance in Q2 2024
Shares of Southwest Airlines Co. (NYSE: LUV) were up over 6% on Thursday after the company beat earnings estimates for the second quarter of 2024. The stock has gained 4%